BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33239755)

  • 21. Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse.
    Kahlert C; Weber H; Mogler C; Bergmann F; Schirmacher P; Kenngott HG; Matterne U; Mollberg N; Rahbari NN; Hinz U; Koch M; Aigner M; Weitz J
    Br J Cancer; 2009 Aug; 101(3):457-64. PubMed ID: 19603023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases.
    Hong SH; Tilan JU; Galli S; Izycka-Swieszewska E; Polk T; Horton M; Mahajan A; Christian D; Jenkins S; Acree R; Connors K; Ledo P; Lu C; Lee YC; Rodriguez O; Toretsky JA; Albanese C; Kitlinska J
    Oncotarget; 2015 Mar; 6(9):7151-65. PubMed ID: 25714031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivation of ICAM1 inhibits metastasis and improves the prognosis of Ewing's sarcoma.
    Pan B; Bu X; Cao M; Zhang X; Huo T; Li Z; Gao X; Jing L; Luo X; Feng H; Yuan F; Guo K
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):393-401. PubMed ID: 33104883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA sequencing and functional studies of patient-derived cells reveal that neurexin-1 and regulators of this pathway are associated with poor outcomes in Ewing sarcoma.
    Roundhill EA; Chicon-Bosch M; Jeys L; Parry M; Rankin KS; Droop A; Burchill SA
    Cell Oncol (Dordr); 2021 Oct; 44(5):1065-1085. PubMed ID: 34403115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA expression profiling and the role of ALCAM modulating tumor growth and metastasis in benzo[a]pyrene-transformed 16HBE cells.
    Li L; Chen J; Wang Y; Zhou C; Ma X; Fu J; Yao B; Zhao P
    Toxicology; 2020 Sep; 442():152539. PubMed ID: 32681969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype, promoting lung metastasis in Ewing sarcoma.
    von Heyking K; Calzada-Wack J; Göllner S; Neff F; Schmidt O; Hensel T; Schirmer D; Fasan A; Esposito I; Müller-Tidow C; Sorensen PH; Burdach S; Richter GHS
    Mol Oncol; 2017 Sep; 11(9):1288-1301. PubMed ID: 28319320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein phosphatase 1 regulatory subunit 1A in ewing sarcoma tumorigenesis and metastasis.
    Luo W; Xu C; Ayello J; Dela Cruz F; Rosenblum JM; Lessnick SL; Cairo MS
    Oncogene; 2018 Feb; 37(6):798-809. PubMed ID: 29059150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ALCAM a novel biomarker in patients with type 2 diabetes mellitus complicated with diabetic nephropathy.
    Sulaj A; Kopf S; Gröne E; Gröne HJ; Hoffmann S; Schleicher E; Häring HU; Schwenger V; Herzig S; Fleming T; Nawroth PP; von Bauer R
    J Diabetes Complications; 2017 Jun; 31(6):1058-1065. PubMed ID: 28325697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular inversion probe analysis detects novel copy number alterations in Ewing sarcoma.
    Jahromi MS; Putnam AR; Druzgal C; Wright J; Spraker-Perlman H; Kinsey M; Zhou H; Boucher KM; Randall RL; Jones KB; Lucas D; Rosenberg A; Thomas D; Lessnick SL; Schiffman JD
    Cancer Genet; 2012; 205(7-8):391-404. PubMed ID: 22868000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma.
    Garcia-Monclús S; López-Alemany R; Almacellas-Rabaiget O; Herrero-Martín D; Huertas-Martinez J; Lagares-Tena L; Alba-Pavón P; Hontecillas-Prieto L; Mora J; de Álava E; Rello-Varona S; Giangrande PH; Tirado OM
    Int J Cancer; 2018 Sep; 143(5):1188-1201. PubMed ID: 29582409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Syntenin-1 and ezrin proteins link activated leukocyte cell adhesion molecule to the actin cytoskeleton.
    Tudor C; te Riet J; Eich C; Harkes R; Smisdom N; Bouhuijzen Wenger J; Ameloot M; Holt M; Kanger JS; Figdor CG; Cambi A; Subramaniam V
    J Biol Chem; 2014 May; 289(19):13445-60. PubMed ID: 24662291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The posterior HOXD locus: Its contribution to phenotype and malignancy of Ewing sarcoma.
    von Heyking K; Roth L; Ertl M; Schmidt O; Calzada-Wack J; Neff F; Lawlor ER; Burdach S; Richter GH
    Oncotarget; 2016 Jul; 7(27):41767-41780. PubMed ID: 27363011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients.
    Tachezy M; Zander H; Gebauer F; Marx A; Kaifi JT; Izbicki JR; Bockhorn M
    J Surg Res; 2012 Sep; 177(1):e15-20. PubMed ID: 22482754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 negatively regulates the hepatoma growth factor HDGF.
    Sasaki Y; Negishi H; Idogawa M; Yokota I; Koyama R; Kusano M; Suzuki H; Fujita M; Maruyama R; Toyota M; Saito T; Tokino T
    Cancer Res; 2011 Nov; 71(22):7038-47. PubMed ID: 22006999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The interaction of hepatoma-derived growth factor and β-catenin promotes tumorigenesis of synovial sarcoma.
    Tang J; Shi H; Li H; Zhen T; Dong Y; Zhang F; Yang Y; Han A
    Tumour Biol; 2016 Aug; 37(8):10287-301. PubMed ID: 26842923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting ALCAM in the cryo-treated tumour microenvironment successfully induces systemic anti-tumour immunity.
    Kudo-Saito C; Fuwa T; Kawakami Y
    Eur J Cancer; 2016 Jul; 62():54-61. PubMed ID: 27208904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States.
    Pedersen EA; Menon R; Bailey KM; Thomas DG; Van Noord RA; Tran J; Wang H; Qu PP; Hoering A; Fearon ER; Chugh R; Lawlor ER
    Cancer Res; 2016 Sep; 76(17):5040-53. PubMed ID: 27364557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association between let-7, RAS and HIF-1α in Ewing Sarcoma tumor growth.
    Hameiri-Grossman M; Porat-Klein A; Yaniv I; Ash S; Cohen IJ; Kodman Y; Haklai R; Elad-Sfadia G; Kloog Y; Chepurko E; Feinmesser M; Issakov J; Sher O; Luria D; Kollender Y; Weizman A; Avigad S
    Oncotarget; 2015 Oct; 6(32):33834-48. PubMed ID: 26393682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-483-5p promotes invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1 and ALCAM.
    Song Q; Xu Y; Yang C; Chen Z; Jia C; Chen J; Zhang Y; Lai P; Fan X; Zhou X; Lin J; Li M; Ma W; Luo S; Bai X
    Cancer Res; 2014 Jun; 74(11):3031-42. PubMed ID: 24710410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor suppressive ZBTB4 inhibits cell growth by regulating cell cycle progression and apoptosis in Ewing sarcoma.
    Yu Y; Shang R; Chen Y; Li J; Liang Z; Hu J; Liu K; Chen C
    Biomed Pharmacother; 2018 Apr; 100():108-115. PubMed ID: 29425745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.